Veracyte, Inc. Files 8-K on Financials
Ticker: VCYT · Form: 8-K · Filed: Aug 6, 2024 · CIK: 1384101
| Field | Detail |
|---|---|
| Company | Veracyte, Inc. (VCYT) |
| Form Type | 8-K |
| Filed Date | Aug 6, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, results-of-operations
Related Tickers: VCYT
TL;DR
VCYT dropped an 8-K on financials, check it out.
AI Summary
On August 6, 2024, Veracyte, Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements and exhibits, providing an update on the company's performance. Veracyte, Inc. is incorporated in Delaware and headquartered in South San Francisco, California.
Why It Matters
This filing provides investors with crucial, up-to-date information on Veracyte's financial health and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- VERACYTE, INC. (company) — Registrant
- August 6, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- South San Francisco, California (location) — Principal executive offices
- CALDEROME INC (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing for Veracyte, Inc.?
The primary purpose of this 8-K filing is to report on Veracyte, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on August 6, 2024.
In which state is Veracyte, Inc. incorporated?
Veracyte, Inc. is incorporated in Delaware.
What is Veracyte, Inc.'s principal executive office address?
Veracyte, Inc.'s principal executive offices are located at 6000 Shoreline Court, Suite 300, South San Francisco, California 94080.
Was Veracyte, Inc. previously known by another name?
Yes, Veracyte, Inc. was formerly known as CALDEROME INC, with a date of name change on December 19, 2006.
Filing Stats: 507 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-08-06 16:16:25
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share VCYT The Nasdaq Stock Market
Filing Documents
- vcyt-20240806.htm (8-K) — 28KB
- vcyt-08x06x20248xkearningsa.htm (EX-99.1) — 291KB
- vcytlogoa.gif (GRAPHIC) — 6KB
- 0001384101-24-000116.txt ( ) — 473KB
- vcyt-20240806.xsd (EX-101.SCH) — 2KB
- vcyt-20240806_lab.xml (EX-101.LAB) — 22KB
- vcyt-20240806_pre.xml (EX-101.PRE) — 13KB
- vcyt-20240806_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On August 6, 2024, Veracyte, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2024. The full text of the press release is furnished as Exhibit 99.1 to this report. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release issued by Veracyte, Inc. dated August 6 , 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 6, 2024 VERACYTE, INC. By: /s/ Rebecca Chambers Name: Rebecca Chambers Title: Chief Financial Officer Principal Financial Officer